Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--United Bankshares Boosts Quarterly Dividend to $0.38 From $0.37 a Share; Payable Jan. 2 to Holders of Record on Dec. 12
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--United Bankshares Boosts Quarterly Dividend to $0.38 From $0.37 a Share; Payable Jan. 2 to Holders of Record on Dec. 12
Nov 20, 2025 1:29 PM
02:23 PM EST, 11/20/2025 (MT Newswires) --
Price: 35.63, Change: +0.03, Percent Change: +0.10
Previous page:
Sector Update: Consumer
Next page:
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Sector Update: Consumer
Oct 10, 2025
01:13 PM EDT, 10/10/2025 (MT Newswires) -- Consumer stocks were mixed Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) up 0.5% and the Consumer Discretionary Select Sector SPDR Fund (XLY) dropping 2.4%. In corporate news, Levi Strauss (LEVI) shares fell nearly 12% after it issued a downbeat fiscal Q4 profit outlook amid tariff pressures, even as it...
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
Oct 10, 2025
Raises Concerns About Whether the Board Fulfilled Its Fiduciary Duty of Care in Doubling Down on Its Commitment to Proposed Transaction Renewed Support Comes After Stunning Revelation STAAR CEO and Chair Failed to Disclose Inbound Interest in Acquiring the Company to Rest of Board NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following...
Market Chatter: Novo Nordisk Halts Cell Therapy Work on Diabetes to Cut Costs
Oct 10, 2025
01:11 PM EDT, 10/10/2025 (MT Newswires) -- Novo Nordisk ( NVO ) is winding down its cell therapy division that had been working on a potential cure for type 1 diabetes, Bloomberg reported Friday, citing a company statement. Novo said it is seeking partners to continue developing its cell therapy projects, according to the report. Almost all of the division's...
Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report
Oct 10, 2025
Johnson & Johnson ( JNJ ) is reportedly in discussions to acquire Protagonist Therapeutics ( PTGX ) . Citing people close to the talks, the Wall Street Journal reported that the deal is not guaranteed, and the terms have yet to be finalized. Year to date, Protagonist Therapeutics' ( PTGX ) stock has gained around 132%, as per data from...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP